Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Tune in to our latest podcast with leading experts who discuss the importance of patient-reported outcomes in CAR-T...

  • 1560522201027280896 Profile photo of Madelyn

    📣 Tune in to our latest podcast, where leading experts discuss the importance of analyzing patient-reported outcomes in CAR-T recipients. 🎧: https://t.co/iavyo887ZV #HemOnc #ImmunoOnc #CARTcell #tcellrx - view on twitter

John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, discusses patient risk stratification in chronic...

Won Seog Kim, MD, PhD, Sungkyunkwan University School of Medicine, Seoul, South Korea, discusses the importance of plasma circulating...

Mashup Score:3

VJHemOnc

CAR-T therapy has revolutionized the treatment landscape of several hematological malignancies, and ongoing clinical trials continue to provide valuable...

  • 1558091955254460421 Profile photo of Madelyn

    🚨 We've just posted a new podcast on #CART therapy in #Lymphoma & #MultipleMyeloma! 🎧 Listen to it here: 👉https://t.co/BKRVSW44By 👈 @VJHemOnc #iwCART22 #HemOnc #LYMsm #NonHodgkinLymphoma #DLBCL #FollicularLymphoma #MantleCellLymphoma #MMSM #Myeloma #ImmunoOnc #tcellrx - view on twitter

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, discusses advances in allogeneic CAR-T therapy for the treatment of relapsed/refractory...

Learn more about the importance of genomic testing in CLL and how this influences clinical decision making with expert-led...

  • 1559087938297905154 Profile photo of Madelyn

    Learn more about the importance of genomic testing in CLL w/ leading experts in our feature, covering: ➡️ the definition of high-risk disease ➡️ the role of genomic testing in prognosis ➡️ TP53 testing & more! 👉https://t.co/N7zOMFb3gZ👈 #CLLsm #LeuSM #HemOnc - view on twitter

In this video, Santosh Saraf, MD, University of Illinois Hospital, Chicago, IL, briefly discusses strategies to manage kidney disease...

Jahanzaib Khwaja, MD, FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, comments on unmet needs in patients...

Shuh Ying Tan, MBBS, BMedSci, FRACP, FRCPA, St Vincent’s Hospital Melbourne, Melbourne, Australia, briefly discusses the current standard of...

On August 17 2022, the US Food and Drug Administration (FDA) approved the first cell-based gene therapy, betibeglogene autotemcel...

  • 1560628711673761795 Profile photo of Madelyn

    📣 On August 17th, 2022, betibeglogene autotemcel received FDA approval for patients with transfusion-dependent β-thalassemia. Read more about it in our latest feature: 👉https://t.co/2SiaIzDijE👈 #HemOnc #RareDiseases #Thalassemia - view on twitter